Tessellate Bio is a biotechnology company focusing on novel synthetic lethality approaches beyond Homologous Recombination Deficiency (HRD)
Tessellate Bio is a biotechnology company focusing on novel synthetic lethality approaches beyond Homologous Recombination Deficiency (HRD). We are discovering and developing new precision oncology medicines with the mission to turn cancer patients into cancer survivors.